- Filed
- Jul 16, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Jul 16, 2024 | 1.48B sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $23.58K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $21.59K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$9.14M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$9.08M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $9.75M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $9.69M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $23.58K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $21.59K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $589.73K |
| Total Assets | Q1 2024 · Dec 31, 2023 | $587.74K |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 248.11M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$149.25K |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $45.5K |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $1.33K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$526.4K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$213.74K |